Kolundzić Robert, Orlić Dubravko, Trkulja Vladimir, Pavelić Kresimir, Troselj Koraljka Gall
Department of Orthopaedic Surgery, Clinical Hospital Center Zagreb and University School of Medicine, Salata 3, 10000, Zagreb, Croatia.
J Orthop Sci. 2006 Nov;11(6):592-600. doi: 10.1007/s00776-006-1069-y. Epub 2006 Dec 4.
Aseptic loosening resulting from inflammatory response to the implant wear debris is the major cause of late total hip arthroplasty (THA) failure. We examined single nucleotide polymorphisms in genes encoding for three involved cytokines--interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and transforming growth factor-beta1 (TGF-beta1)--as potential predictors of time to onset of aseptic instability.
A total of 41 patients/45 total hip endoprostheses (same type, same surgeon) were followed up for as long as 18 years. They were genotyped for the IL-6 promoter (-597G-->A) and (-572G-->C), TNF-alpha promoter (-308G-->A), and TGF-beta1 signal sequence (29T-->C) transitions. Cox regression was performed on the prosthesis survival.
Overall, 22 of 45 prostheses developed aseptic instability. Cumulative survivals at 10 and 15 years after THA were 95.6% and 66.6%, respectively. The effect of a particular polymorphic site was estimated with adjustment for sex, age at THA, reason for THA, and the effects of other analyzed sites. The hazard ratio (HR) for genotype T/T versus "C-allele carriage" at the TGF-beta1 site was 8.23 [95% confidence interval (CI) 1.45-46.8] (P=0.017) or 5.70 (1.39-23.4) (P=0.016) when the IL-6 promoter sites were considered as a "combination of genotypes (-597)|(-572)." The most prevalent combination of genotypes at IL-6 sites was G/A (-597)|C/C (-572). HR for this combination (versus other combinations) was 5.43 (1.73-17.0) (P=0.004) when "TGF-beta1 (29T-->C)" was considered as a three-level factor (three possible genotypes), and 4.92 (1.71-14.1) (P=0.003) when TGF-beta1 site was considered as a two-level factor (T/T and "C-allele carriage"). The HR for the "A-allele carriage" at TNF-alpha (-308G-->A) could not be determined (only two patients had the G/G genotype).
This preliminary study is the first to suggest that the TGF-beta1 signal sequence (29T-->C) and IL-6 promoter (-597G-->A)|(-572G-->C) transitions are predictive for the time to onset of aseptic instability after THA.
植入物磨损碎屑引发的炎症反应导致的无菌性松动是全髋关节置换术(THA)晚期失败的主要原因。我们检测了编码三种相关细胞因子——白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)和转化生长因子-β1(TGF-β1)——的基因中的单核苷酸多态性,作为无菌性松动发生时间的潜在预测指标。
共对41例患者/45个全髋关节假体(同一类型,同一外科医生操作)进行了长达18年的随访。对他们进行了IL-6启动子(-597G→A)和(-572G→C)、TNF-α启动子(-308G→A)以及TGF-β1信号序列(29T→C)转换的基因分型。对假体生存率进行Cox回归分析。
总体而言,45个假体中有22个出现无菌性松动。THA术后10年和15年的累积生存率分别为95.6%和66.6%。通过对性别、THA时的年龄、THA的原因以及其他分析位点的影响进行校正,估计了特定多态性位点的效应。当将IL-6启动子位点视为“基因型(-597)|(-572)的组合”时,TGF-β1位点基因型T/T与“C等位基因携带”相比的风险比(HR)为8.23 [95%置信区间(CI)1.45 - 46.8](P = 0.017),或5.70(1.39 - 23.4)(P = 0.016)。IL-6位点最常见的基因型组合是G/A(-597)|C/C(-572)。当将“TGF-β1(29T→C)”视为三级因素(三种可能的基因型)时,该组合(与其他组合相比)的HR为5.43(1.73 - 17.0)(P = 0.004);当将TGF-β1位点视为二级因素(T/T和“C等位基因携带”)时,HR为4.92(1.71 - 14.1)(P = 0.003)。TNF-α(-308G→A)处“A等位基因携带”的HR无法确定(只有两名患者为G/G基因型)。
这项初步研究首次表明,TGF-β1信号序列(29T→C)和IL-6启动子(-597G→A)|(-572G→C)转换可预测THA后无菌性松动的发生时间。